| J9271 | Injection, pembrolizumab, 1 mg | 5,000 | $40 | $215K |
| J0897 | Injection, denosumab, 1 mg | 6,540 | $20 | $117.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 480 | $150 | $69.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 560 | $100 | $54.5K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 580 | $80 | $46.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 320 | $120 | $38.2K |
| Q5116 | Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg | 1,970 | $20 | $35.5K |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 870 | $40 | $33.1K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 210 | $50 | $11.4K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 50 | $180 | $8.9K |